Researchers have developed a new imaging technology called SmartIQ that significantly reduces the amount of X-ray radiation used during coronary procedures while enhancing image quality. This innovation, created by Royal Philips in collaboration with leading cardiovascular centers, employs an ultra-low dose protocol that uses over 50% less radiation compared to previous methods. This advancement aims to help doctors obtain clearer images without exposing patients and medical staff to high radiation levels.

For people concerned about heart health and longevity, this technology could mean safer and more effective coronary procedures. Reduced radiation exposure is particularly important for those undergoing multiple imaging tests, as it lowers the risk of radiation-related health issues. The initial clinical pilot study showed that SmartIQ provided better image quality in most comparisons while maintaining or lowering radiation and contrast doses, which is a significant benefit for anyone needing heart care.

The research behind SmartIQ is still in the early stages, with the first blinded clinical pilot study recently published. While the results are promising, it’s important to note that further studies are ongoing, including the RADIQAL trial, which aims to confirm these findings in larger populations. As of now, SmartIQ is available in Europe and select markets but has not yet been cleared for use in the United States.

If you’re interested in heart health, staying informed about advancements like SmartIQ can be beneficial. While waiting for broader availability, you might consider discussing any concerns about radiation exposure with your healthcare provider, especially if you need regular imaging tests.

Source: globenewswire.com